In this edition of the Bottom Line blog, NCI Director Dr. W. Kimryn Rathmell discusses NCI's fiscal year 2024 appropriation from Congress, which increases the base budget, but also reflects the end of dedicated funding for the Cancer Moonshot. The budget allows NCI to prioritize funding for new grants, particularly to early-stage investigators; training mechanisms; and Cancer Centers, while limiting the impact on continuing grants.
This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892
No comments:
Post a Comment